baber/WOPTO huggingface dataset:
Patent DE-69328628-D1 (DE)
Inventor: BARTZ M
IPC: C08K3/04
Filed: 1993-12-14
Granted: 2000-06-15
Abstract: Disclosed is a method of insulating a surface or enclosure by applying to the surface or enclosure a polymeric foam structure of a polymer material and carbon black. The carbon black is generally uniformly dispersed in the polymer matrix in the form of discrete, individual particles substantially free of agglomeration. A preferred carbon black is thermal black. The carbon black is easily processed and integrated into the present structure, and provides a lower thermal conductivity for a given loading. Further disclosed is a process for making the foam structure. Further disclosed is an extruded, insulative foam structure of the type described above.
Patent DE-69329656-D1 (DE)
Inventor: BOON-FALLEUR THIERRY
IPC: C12N5/0783
Filed: 1993-12-14
Granted: 2000-12-14
Abstract: The invention relates to complexes of human leukocyte antigen molecules and tyrosinase derived peptides SEQ ID NO: 2, on the surfaces of abnormal cells. The therapeutic and diagnostic ramifications of this observation are the subject of the invention.
Patent DE-69330966-D1 (DE)
Inventor: WOLF PROF DR
IPC: C12N1/21
Filed: 1993-07-23
Granted: 2001-11-22
Abstract: The application describes the identification of an Epstein-Barr virus (EBV) encoded gene and rapid methods for construction of plasmids efficiently expressing this or other genes. The EBV gene can be purified and used as an antigen for diagnosis and therapy of EBV related diseases. <IMAGE>
Patent DE-69332688-D1 (DE)
Inventor: POTEMPA A
IPC: A61K49/00
Filed: 1993-04-22
Granted: 2003-03-20
Abstract: The invention provides a method of treating cancer in a mammal comprising administering to the mammal an effective amount of modified C-reactive protein ("mCRP"). The invention also provides a method of treating cancer in a mammal comprising administering to the mammal mCRP in combination with another agent such as a chemotherapeutic compound, immunoadjuvant, or cytokine. The mCRP may be administered to the mammal in a pharmaceutically-acceptable carrier or in liposomes. The invention further provides a method of identifying cancer cells in a mammal using mCRP as an imaging agent.
Patent DE-69333839-D1 (DE)
Inventor: PAQUET ANDREW N
IPC: C08J9/12
Filed: 1993-06-08
Granted: 2005-08-11
Abstract: Disclosed is an insulative, bimodal aromatic polymer foam structure having microscopic pinholes in the cell walls to enhance the flexibility of the foam structure. Further disclosed is an insulative, bimodal alkenyl aromatic polymer foam structure containing carbon black. Further disclosed is a process for making low density alkenyl aromatic polymer foams prepared with a halogen-free blowing agent of carbon dioxide, lower alcohol and water. The cell size can be effectively controlled by controlling the amount of water in the blowing agent.
Patent DE-69401655-D1 (DE)
Inventor: TAKAHASHI YASUNORI
IPC: H01F1/34
Filed: 1994-08-17
Granted: 1997-03-13
Abstract: It is an object of the present invention to provide a process of producing a ferrite compact superior in the dimensional stability with scarce thermal contraction after compacting, and providing an easy and dust-explosion-free method of producing a hard ferrite compact is another object. A method of preparing a ferrite compact according to the present invention is that a mixture of powdery raw materials for ferrite is roasted at 1200-1400 DEG C to obtain a powdery ferrite; the powdery ferrite is cooled to a temperatures below the melting temperature of a powdery vitrification agent, then mixed with the powdery vitrification agent to obtain the powdery ferrite coated with the vitrification agent; and the coated powdery ferrite is compacted under heating at a temperature between the melting temperature of the vitrification agent and 700 DEG C.
Patent DE-69405816-D1 (DE)
Inventor: BROWN GEORGE ROBERT
IPC: C07D211/26
Filed: 1994-06-23
Granted: 1997-10-30
Abstract: The invention concerns allophanic acid derivatives of formula I R<1>-N(R<2>)CO-N(R<3>)CO-X<1>-Q-X<2>-G   I and pharmaceutically acceptable metabolically labile esters or amides thereof, and pharmaceutically acceptable salts thereof, in which R<1>, R<2>, R<3>, X<1>, Q, X<2> and G have the meanings given in the specification. The invention also concerns processes for the preparation of the allophanic acid derivatives of formula I, pharmaceutical compositions containing them and their use as inhibitors of the binding of fibrinogen to glycoprotein IIb/IIIa.
Patent DE-69405909-D1 (DE)
Inventor: BUFFARD MAURICE
IPC: G02C5/22
Filed: 1994-04-27
Granted: 1997-11-06
Abstract: In a spring-loaded hinge for spectacles, the side knuckle (26) is prolonged by a slide (20) which can move in a housing (12) against the action of a spring (30). This spring is housed in a central longitudinal space in the slide and acts between the rear end (27) of the slide and a stopper acting as a lock (40). The lock (40) is made in the form of a plate which has the shape of a circular sector whose apex angle is greater than 100 degrees, the lock being inserted into a slot (22) made through the slide (20). The front end of the spring (30) bears against one of the radii of the lock in such a way that the end of the other radius emerges from the slot in order to catch in an orifice (13) made in the lateral wall of the housing (12). <IMAGE>
Patent DE-69407945-D1 (DE)
Inventor: BORGSTEDT ERIC
IPC: B01J20/10
Filed: 1994-08-16
Granted: 1998-02-19
Abstract: A particulate amorphous alkali metal silicate is prepared by heating a mixture of silicate glass and water or aqueous solution to a temperature of about 300 DEG -400 DEG  C. to provide a foamed material that is easily formed into particles of less than 20 microns. After careful hydration, a product having 1-15% water based on loss of ignition (LOI) of product at 800 DEG  C. is produced that controls the activity of magnesium in solutions and is, therefore, a useful detergent ingredient.
Patent DE-69408407-D1 (DE)
Inventor: HARDIGG JAMES S
IPC: B65D25/28
Filed: 1994-11-15
Granted: 1998-03-12
Abstract: A light weight handle assembly (10) for a heavy duty container which may contain sensitive electronic components generally comprises a stationery bracket (12) which mounts to a container wall (14) and a movable handle (16) pivotally connected to the bracket (12). The handle (16) is pivotal to a disengaged position (Figure 7) allowing the handle (16) to be assembled to and disassembled from the bracket (12) when the bracket (12) is not attached to the wall (14) and is prevented from pivoting to the disengaged position when the bracket (12) is attached to the wall (14). The bracket (12) and handle (14) are formed with respective stop members (18,20;22,24) that engage in an operative position (Figure 6) of the handle and have substantially planar contact surfaces (70;72) which increase the effective contact area and reduce the compressive stress in the stop members (18,20;22,24). <IMAGE>
Patent DE-69432225-D1 (DE)
Inventor: KINZLER W
IPC: C12Q1/68
Filed: 1994-12-13
Granted: 2003-04-10
Abstract: A two-pronged method for diagnosis of genetic diseases can detect mutations in about 87% of familial adenomatous polyposis (FAP) patients. One part of the diagnostic method employs in vitro protein synthesis from surrogate genes created by amplifying either cDNA or genomic DNA. The second part of the diagnostic method employs an allele-specific expression assay which distinguishes the amount of mRNA expressed in vivo from each of a patient's two alleles. These approaches are readily applicable to the diagnosis of other genetic diseases.
Patent DE-69433346-D1 (DE)
Inventor: D AMBRA THOMAS E
IPC: C07D211/20
Filed: 1994-06-21
Granted: 2003-12-24
Abstract: The invention relates to compounds of the formulae I, II and IX <CHEM>  wherein     R3 is -COOH or -COOR4;   R4 is an alkyl with 1 to 6 carbon atoms; A is the substituents of its ring, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy.   X<+> is a Lewis acid   X is halogen.   The compounds are useful as intermediates and processes for their preparation are also disclosed.
Patent DE-69500418-D1 (DE)
Inventor: ZANUSSO PIETRO
IPC: E06B9/78
Filed: 1995-12-13
Granted: 1997-08-14
Abstract: A device for supporting and controlling a roller blind which includes a chain (68) which if operated in one direction causes the progressive lowering of the blind web (2) and pulled in the other direction causes the rapid raising of the web (2). A specific mechanism adapted to provide this kind of operation is described. <IMAGE>
Patent DE-69525353-D1 (DE)
Inventor: JONES PETER TIMOTHY
IPC: B65D25/28
Filed: 1995-09-14
Granted: 2002-03-21
Abstract: A container of the type which can be lifted and carried by a person, the container comprising a bottom wall, a top wall, a back wall, which faces the person's body when the container is carried, a front wall opposite to the back wall, two opposed side walls extending between the back and front walls, a first hand-grippable portion positioned at the juncture between the bottom wall and one of the side walls, and a second hand-grippable portion positioned adjacent the juncture between the front wall and the other of the side walls.
Patent DE-69532925-D1 (DE)
Inventor: PILOSOF DAVID
IPC: D06M23/06
Filed: 1995-07-26
Granted: 2004-05-27
Abstract: The present invention relates to a stable, aqueous odor-absorbing composition for use on inanimate surfaces. The composition comprises from about 0.1% to about 5% of solubilized, uncomplexed cyclodextrin, preferably, an effective amount of a solubilized, water-soluble antimicrobial preservative having a water-solubility of greater than about 0.3%, preferably, from about 0% to about 10%, by weight of the composition, of solubilized, water-soluble metallic salt, aqueous carrier and wherein said composition is essentially free of any material that would soil or stain fabric and wherein said composition is essentially free of perfume and has a pH of greater than about 3.
Patent DE-69535375-D1 (DE)
Inventor: FAURE FLORENCE
IPC: C12P21/08
Filed: 1995-05-05
Granted: 2007-03-15
Abstract: Soluble polypeptide fraction consisting of all or part of one at least one of the four immunoglobulin-type extracellular LAG-3 protein domains (amino acids 1-159, 160-230, 240-330 and 331-412 of the SEQ ID NO:1 sequence) or consisting of one peptide sequence derived from these domains by replacement, addition or deletion of one or more amino acids. The fraction of the invention has a specificity at least equal to that of LAG-3 in relation to its ligand.
Patent DE-69610879-D1 (DE)
Inventor: LANGEVELD CORNELIS
IPC: C12Q1/04
Filed: 1996-02-01
Granted: 2000-12-14
Abstract: The present invention relates to a microbioligcal test method for detecting antibacterial compounds in liquid samples such as milk, meat juice, serum and urine. The method employs an acid-base or redox indicator to detect growth of a test organism and is characterised in that a thermophilic strain of Bacillus or Streptococcus, e.g. Bacillus stearothermophilus var. calidolactis C953, is employed at a concentration of above 10<7 >CFU/ml, preferably between 2x10<7 >and 3x10<8 >CFU/ml.
Patent DE-69618772-D1 (DE)
Inventor: LUNDELL JUHANI
IPC: C07K7/00
Filed: 1996-03-01
Granted: 2002-03-14
Abstract: PCT No. PCT/FI96/00120 Sec. 371 Date Nov. 12, 1997 Sec. 102(e) Date Nov. 12, 1997 PCT Filed Mar. 1, 1996 PCT Pub. No. WO96/27607 PCT Pub. Date Sep. 12, 1996A process is provided for the preparation of pure cyclosporin which is purified chromatographically from a mixture of different cyclosporin forms and other substances prepared by fermentation. The process comprises feeding a mixture containing a desired form of cyclosporin with an eluent consisting of high pressure carbon dioxide and an adjuvant, into a chromatography column being packed with particles prepared of silica, and recovering from the eluent flow coming out of the chromatography column a fraction which contains the desired cyclosporin form in adequately pure form.
Patent DE-69628688-D1 (DE)
Inventor: MUEHL BRIAN STEPHEN
IPC: A61K31/445
Filed: 1996-03-06
Granted: 2003-07-24
Abstract: This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 3-benzyl-benzofurans which are  alpha -substituted with ether, thioether, amino, hydrazino cyano or halo that are useful for the treatment of the various medical indications associated with post-menopausal syndrome, as well as estrogen dependent diseases including cancer of the breast, uterus and cervix. The present invention further relates to intermediate compounds and processes useful for preparing the pharmaceutically active compounds of the present invention, and pharmaceutical compositions.
Patent DE-69634917-D1 (DE)
Inventor: BENBADIS LAURENT
IPC: A23C9/12
Filed: 1996-10-31
Granted: 2005-08-11
Abstract: A Lactobacillus acidophilus strain as well as lactic starters and fermented dairy products using said strain and having cholesterol-lowering properties, are disclosed.
Patent DE-69700724-D1 (DE)
Inventor: BARANI RUGGERO
IPC: A23F5/00
Filed: 1997-06-17
Granted: 1999-12-09
Abstract: A tablet for preparation of a coffee drink comprises a pressed mixture of ground coffee and at least one hydrophile substance, able to absorb water and in doing so increasing in volume. The tablet is conformed and sized such as to be insertable in a cup-filter and is destined in use to undergo a process of extraction of parts of the coffee which are soluble in water. A process for realising the table comprises a mixture of the ground coffee with a hydrophile substance and a compression of the mixture thus obtained.
Patent DE-69704824-D1 (DE)
Inventor: KNAPP ALFONS
IPC: G05D23/13
Filed: 1997-03-26
Granted: 2001-06-21
Abstract: A retaining device for frictionally retaining two mobile parts of a thermostatically controlled mixing valve. The first part (2) of the mixing valve contains a cavity having a side wall (40), a top wall (41) and a bottom wall (42). An O-ring type packing washer (9) is disposed in the cavity and frictionally grips a surface of the second mobile part (13). The axial distance between top wall (41) and bottom wall (42) of the cavity is less than the cross-sectional diameter in the axial direction of the ring-shaped packing washer (9). The packing washer (9) is thus compressed axially and establishes a frictional hold between the top wall (41) and bottom wall (42) of the cavity and the axially extending surface of the second mobile part (13). The diameter of the cavity is greater than the diameter of the compressed ring-shaped packing washer (9) thereby forming a ring-shaped space or chamber between the washer (9) and the side wall (40). This ring-shaped space communicates with a water holding area of the mixing valve through a groove (43) in the bottom wall (42) of the cavity.
Patent DE-69710606-D1 (DE)
Inventor: OLSSON RAY
IPC: G01L9/12
Filed: 1997-12-12
Granted: 2002-03-28
Abstract: PCT No. PCT/IB97/01562 Sec. 371 Date Jul. 1, 1999 Sec. 102(e) Date Jul. 1, 1999 PCT Filed Dec. 12, 1997 PCT Pub. No. WO98/26262 PCT Pub. Date Jun. 18, 1998A method for electronic compensation of erroneous readings is based on the observation that a sensor serving as a transducer is caused to resonate. The erroneous reading caused by the resonance is measured and a compensation signal is feedback into the measurement element, the signal being essentially unfiltered. An apparatus uses error detection and compensation circuits whose upper barrier frequency are above the resonance frequency of the transducer for detecting an error signal caused by resonance in the transducer and for generating a compensation signal for feeding into the detector sensor.
Patent DE-69710893-D1 (DE)
Inventor: LEIJONBERG GUNNAR
IPC: F02B75/00
Filed: 1997-07-10
Granted: 2002-04-11
Abstract: The present invention is for the kind of power machine, engines, pumps or compressors which have two or more pistons which work against each other preferably with a common combustion space or corresponding in a stationary cylinder, and where the power is transmitted to or from a rotating motion without an intermediate crankshaft. Independent of whether the machine works as engine, pump or compressor there is a need to cool the cylinder. For applications such as engines for lawn-mowers and power saws the engines must be air-cooled as in practice it is not possible to arrange a water-cooling system. Cooling of the cylinder is obtained by that holes or channels (30, 31) are arranged both in the rotating and the stationary discs and cooling air is made to flow through these channels. In order to further improve the cooling the outside of the cylinder may have flanges. In other embodiments of the invention the connecting means between the rotating disc and the outgoing shaft are so shaped that they also function as fan blades (34-35) and cause a desired air flow.
Patent DE-69712055-D1 (DE)
Inventor: SALINI ALBERTO
IPC: A61K38/00
Filed: 1997-05-20
Granted: 2002-05-23
Abstract: A description is given of new pharmaceutical compositions containing cyclosporine, combined with a carrier comprising at least a derivative of alpha-glycerophosphoric acid, such as alpha-glycerophosphorylcholine, alpha-glycerophosphorylserine, alpha-glycerophosphorylethanolamine and alpha-glycerophosphoryl-myo-inositol, which allow cyclosporine bioavailability to significantly increase.
Patent DE-69714767-D1 (DE)
Inventor: DEBRAS GUY
IPC: C08F210/16
Filed: 1997-12-19
Granted: 2002-09-19
Abstract: A process for producing high density polyethylene, the process comprising polymerising ethylene, or copolymerising ethylene and an alpha-olefinic comonomer comprising from 3 to 10 carbon atoms, in the presence of a catalyst system comprising first and second chromium-based catalysts, the first chromium-based catalyst having been reduced and reoxidised and the second chromium-based catalysts having been activated, fluoridised before or during the activation step, and reduced, the first and second chromium-based catalyst having a pore volume different of at least 0.8cc/g. There is further provided a catalyst system for the production of high density polyethylene by polymerising ethylene or copolymerising ethylene and an alpha-olefinic comonomer comprising from 3 to 10 carbon atoms, the catalyst system comprising first and second chromium-based catalysts, the first chromium-based catalyst having been reduced and reoxidised and the second chromium-based catalyst having been activated, fluoridised before or after the activation step, and reduced, and the first and second chromium-based catalysts having a pore volume difference of at least 0.8cc/g. There is further provided the use of the catalyst system for increasing the bimodality of the molecular weight distribution of a high density polyethylene.
Patent DE-69721339-D1 (DE)
Inventor: RAMASAMY KANDASAMY
IPC: A61K31/70
Filed: 1997-10-15
Granted: 2003-05-28
Abstract: Novel monocyclic L-Nucleoside compounds have the general formula  Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.
Patent DE-69726408-D1 (DE)
Inventor: OHNISHI YUKO
IPC: A61K31/555
Filed: 1997-07-04
Granted: 2004-01-08
Abstract: A process for the preparation of cis-platinum(II) complexes of 1,2-cyclohexanediamine isomers, represented by formula I, containing substantially no dihydroxoplatinum(IV) complex as an impurity. <CHEM> Deoxygenated water is used in all steps of the process, from charging of the starting materials; i.e., potassium tetrachloroplatinate and trans-(-)-1,2-cyclohexanediamine, to the acquisition of target complexes. In addition, a low-oxygen content atmosphere is applied as an operational environment to prevent deoxygenated water from degradation through oxygen absorption and to eliminate the possibility of direct oxidation of a platinum compound due to atmospheric oxygen.
Patent DE-69733960-D1 (DE)
Inventor: LAZAROVITS I
IPC: A61K39/395
Filed: 1997-09-17
Granted: 2005-09-15
Abstract: A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
Patent DE-69735558-D1 (DE)
Inventor: BRAIDWOOD JULIAN CHARLES
IPC: A61P31/00
Filed: 1997-07-29
Granted: 2006-05-18
Abstract: The invention relates to the use of bronopol (bromo-2-nitropropane-1,3-diol), in the treatment of various diseases of aquatic organisms, particularly salmonid fish and their eggs. The diseases which can be treated include those caused by fungal infections (such as Saprolegnia parasitica); protozoan infections, whether flagellate (such as Ichthyobodo necatrix) or ciliate (such as Icthyophthirius multifiliis); bacteria (such as Flavobacterium branchiophilum); and myxobacteria (such as Cytophaga psychrophila). Also disclosed is a method of disinfecting fish tanks and/or equipment, using a solution of bronopol.
Patent DE-69736131-D1 (DE)
Inventor: WHITE H
IPC: A61F2/06
Filed: 1997-08-27
Granted: 2006-07-27
Abstract: A system for delivering and implanting a radially expandable endoluminal prosthesis within a body lumen (e.g., blood vessel). The system comprises a) an introducer/dilator assembly, and b) a delivery catheter/loader assembly. The introducer/dilator assembly comprises an elongate tubular introducer sheath which may be provided with a valving assembly mounted on the proximal end thereof. Such valving assembly may incorporate i) a hemostatic valve, ii) a first sealing valve and iii) a second sealing valve, positioned in series, to prevent leakage of body fluid out of the proximal end of the introducer and to permit two or more elongate members (e.g., catheters, guidewires) having differing outer diameters to be inserted through the introducer without leakage of body fluid therefrom. A dilator, which has regionalized differences in stiffness, is initially deployable within the lumen of the introducer to facilitate advancement of the introducer to its desired location within the body. Thereafter, the dilator may be removed from the introducer sheath and the delivery catheter/loader assembly may be attached to the introducer, such that the delivery catheter having the prosthesis mounted thereon may advanced through the introducer, to a desired location within the body. Thereafter, the radial expandable endoluminal prosthesis mounted on the delivery catheter is deployed and implanted by an expansion device (e.g., balloon) formed on the delivery catheter. The delivery catheter may incorporate one or more outflow apertures at specific location(s) to facilitate injection of radiographic contrast medium in a manner which will check for leakage around the endoluminal prosthesis, after the endoluminal prosthesis has been radially expanded and implanted.